Apyx Medical Corporation Engages in Key Investor Conferences
Apyx Medical Corporation (NASDAQ:APYX), a prominent player in advanced energy technology, has confirmed participation in significant upcoming investor conferences. This engagement underscores the company's commitment to connecting with stakeholders and promoting its innovative products, particularly in the fields of cosmetic and surgical technologies.
Scheduled Conference Appearances
Charles Goodwin, President and CEO, along with Matt Hill, CFO, will be representing Apyx Medical at two notable events:
Craig-Hallum Alpha Select Conference
Scheduled for November 18, this conference takes place at the Sheraton NY Times Square Hotel. The format will feature one-on-one meetings, providing a chance for investors to engage directly with leadership from Apyx Medical.
Canaccord Genuity MedTech Forum
On November 20, Apyx Medical will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum at the Westin NY Grand Central. This event also focuses on personalized investor engagement through one-on-one discussions.
Investor Engagement Opportunities
Investors interested in scheduling discussions with Apyx Medical can coordinate through their respective representatives at Craig Hallum and Canaccord Genuity, signifying a proactive approach to investor relations.
About Apyx Medical Corporation
Apyx Medical Corporation is at the forefront of advancing energy technology, dedicated to enhancing lives through groundbreaking medical products. The company is well-known for its Renuvion technology, which is utilized within the cosmetic surgery domain, alongside the AYON Body Contouring System. Renuvion and its counterpart, J-Plasma, provide surgeons with innovative tools to deliver optimal tissue heating for precise results in a variety of surgical applications.
The AYON Body Contouring System is celebrated for its unique design, seamlessly integrating multiple functions like fat removal and tissue contraction, thereby empowering surgeons to offer comprehensive body contouring procedures. This innovative approach enables unparalleled versatility and efficiency in surgical practices. Apyx Medical also maintains partnerships through OEM agreements, showcasing their commitment to advancing medical device technology.
Furthermore, the company’s methods and technologies are backed by extensive clinical research, ensuring reliability and efficacy in their medical offerings. They are continuously working to expand their product range while focusing on meeting the evolving needs of healthcare providers and their patients.
Investor Relations Contact Information
The company is open to dialogues with potential investors and other stakeholders, who are encouraged to reach out to Jeremy Feffer, Managing Director of LifeSci Advisors, at 212-915-2568. Direct inquiries can also be sent via email.
Frequently Asked Questions
What does Apyx Medical Corporation specialize in?
Apyx Medical Corporation focuses on advanced energy technology, particularly in helium plasma and radiofrequency products for surgical applications.
Where will Apyx Medical be presenting its innovations?
Apyx Medical is set to present at the Craig-Hallum Alpha Select Conference and the Canaccord Genuity MedTech Forum in New York.
Who are the key representatives at these conferences?
Charles Goodwin, the President and CEO, and Matt Hill, the CFO, will represent Apyx Medical at the upcoming conferences.
How can investors connect with Apyx Medical?
Investors can request meetings through their representatives at Craig Hallum and Canaccord Genuity.
What is the AYON Body Contouring System?
The AYON Body Contouring System is an FDA-cleared device designed for comprehensive body contouring treatments, combining multiple surgical functions into one platform.
